NZ220100A - Benzothiazinones as calcium antagonists - Google Patents

Benzothiazinones as calcium antagonists

Info

Publication number
NZ220100A
NZ220100A NZ220100A NZ22010087A NZ220100A NZ 220100 A NZ220100 A NZ 220100A NZ 220100 A NZ220100 A NZ 220100A NZ 22010087 A NZ22010087 A NZ 22010087A NZ 220100 A NZ220100 A NZ 220100A
Authority
NZ
New Zealand
Prior art keywords
benzothiazinones
calcium antagonists
antagonists
calcium
Prior art date
Application number
NZ220100A
Inventor
Ulrich Lerch
Rainer Henning
Joachim Kaiser
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NZ220100A publication Critical patent/NZ220100A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
NZ220100A 1986-04-28 1987-04-27 Benzothiazinones as calcium antagonists NZ220100A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863614363 DE3614363A1 (en) 1986-04-28 1986-04-28 BENZOTHIAZINONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, MEDICINAL PRODUCTS CONTAINING THEM AND THE USE THEREOF

Publications (1)

Publication Number Publication Date
NZ220100A true NZ220100A (en) 1990-03-27

Family

ID=6299713

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ220100A NZ220100A (en) 1986-04-28 1987-04-27 Benzothiazinones as calcium antagonists

Country Status (13)

Country Link
EP (1) EP0244723A3 (en)
JP (1) JPS62258371A (en)
KR (1) KR870010028A (en)
AU (1) AU601659B2 (en)
DE (1) DE3614363A1 (en)
DK (1) DK213387A (en)
FI (1) FI871813A (en)
HU (1) HU199814B (en)
IL (1) IL82332A (en)
NO (1) NO871745L (en)
NZ (1) NZ220100A (en)
PT (1) PT84770B (en)
ZA (1) ZA872972B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3724366A1 (en) * 1987-07-23 1989-02-02 Hoechst Ag BENZOTHIAZINONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, MEDICINAL PRODUCTS CONTAINING THEM AND THE USE THEREOF
DE3726759A1 (en) * 1987-08-12 1989-03-09 Hoechst Ag BENZOTHIAZINONE OXIDES, METHOD FOR THE PRODUCTION THEREOF, MEDICINAL PRODUCTS CONTAINING IT AND THEIR USE, AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION
DK0429676T3 (en) * 1989-06-16 1997-03-10 Santen Pharmaceutical Co Ltd
US6207665B1 (en) 1997-06-12 2001-03-27 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
US6693099B2 (en) * 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
BRPI0404222A (en) * 2004-06-07 2006-02-07 Fundacao Oswaldo Cruz Lidocaine derivatives, pharmaceutical compositions containing them, use of the respective pharmaceutical compositions in the treatment, prevention or inhibition of diseases as well as the method of treating, preventing or inhibiting diseases with said pharmaceutical compositions
RU2016152499A (en) * 2014-05-30 2018-07-04 Драг Дискавери Ресеч Сентэ New compounds as anti-TB drugs

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4584300A (en) * 1983-02-07 1986-04-22 Santen Pharmaceutical Co., Ltd. Platelet anti-aggregative- and calcium antagonistic -1,4-benzothiazin-3-one derivatives, compositions, and methods of use therefor
JPS59148771A (en) * 1983-02-09 1984-08-25 Santen Pharmaceut Co Ltd Benzothiazine derivative
DE3347173A1 (en) * 1983-12-27 1985-07-04 Hoechst Ag, 6230 Frankfurt NEW BENZOTHIAZINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, MEDICINAL PRODUCTS CONTAINING THEM AND THE USE THEREOF
EP0186310A1 (en) * 1984-11-28 1986-07-02 Takeda Chemical Industries, Ltd. 1,4-Benzothiazine Derivatives, their production and use
US4739050A (en) * 1985-03-19 1988-04-19 Santen Pharmaceutical Co., Ltd. 2-phenyl-1,4-benzothiazin-3-one derivatives
WO1987000838A1 (en) * 1985-07-29 1987-02-12 Santen Pharmaceutical Co., Ltd. Novel benzothiazine derivatives

Also Published As

Publication number Publication date
DK213387A (en) 1987-10-29
FI871813A (en) 1987-10-29
AU7199487A (en) 1987-10-29
ZA872972B (en) 1987-11-25
EP0244723A2 (en) 1987-11-11
DE3614363A1 (en) 1987-10-29
HUT45517A (en) 1988-07-28
NO871745L (en) 1987-10-29
HU199814B (en) 1990-03-28
IL82332A (en) 1991-08-16
KR870010028A (en) 1987-11-30
PT84770B (en) 1989-12-29
FI871813A0 (en) 1987-04-24
JPS62258371A (en) 1987-11-10
NO871745D0 (en) 1987-04-27
DK213387D0 (en) 1987-04-27
EP0244723A3 (en) 1988-10-19
PT84770A (en) 1987-05-01
AU601659B2 (en) 1990-09-13
IL82332A0 (en) 1987-10-30

Similar Documents

Publication Publication Date Title
EP0270947A3 (en) Substituted basic 2-aminotetralines
IL83589A0 (en) Substituted benzoylphenyl-ureas
GB8715216D0 (en) Calcium salts
IL81209A0 (en) Substituted indoloquinoxalines
GR3000809T3 (en) Anchoring
ZA876302B (en) Substituted 1-aryl-3-tert.-butyl-pyrazoles
EP0240462A3 (en) Substituted aminooxypropanoate
AR243502A1 (en) Certain substituted 3-amino-2-benzoylcyclohex-2-enones
ZW23787A1 (en) Anchoring
NZ220100A (en) Benzothiazinones as calcium antagonists
GR861165B (en) Dihydropyridine calcium antagonists
ZA872432B (en) Substituted aminoxy-propionamides
ZA894755B (en) Lactamimides as calcium antagonists
ZA879548B (en) Substituted n-methylisoxazolidines
GB2187739B (en) Substituted pyrimidoindoles
ZA879546B (en) Substituted phenoxypyridines
ZA883601B (en) Vaspressin antagonists
IE892087L (en) Lactamimides as calcium antagonists
ZA877869B (en) Substituted amino-ketals
GB8614246D0 (en) Substituted pyrimidoindoles
IE861178L (en) Dihydropyridine calcium antagonists.
ZA90841B (en) Calcium antagonists
ZA879254B (en) Substituted basic 2-aminotetralins
CS403886A1 (en) Portlandsky cement so zvysenymi pociatocnymi pevnostami
CS403786A1 (en) Portlandsky cement so zvysenymi pociatocnymi pevnostami